Biotech labs are using AI inspired by DALL-E to invent new drugs | MIT Technology Review
technologyreview.com · 1,553 words · saved by 1 readers
Two groups have announced powerful new generative models that can design new proteins on demand not seen in nature.
Biotech labs are using AI inspired by DALL-E to invent new drugs | MIT Technology Review Skip to Content The explosion in text-to-image AI models like OpenAI’s DALL-E 2 —programs trained to generate pictures of almost anything you ask for—has sent ripples through the creative industries, from fashion to filmmaking, by providing weird and wonderful images on demand. The same technology behind these programs is also making a splash in biotech labs, which have started using this type of generative AI, known as a diffusion model, to conjure up designs for new types of protein never seen in nature.
related reading
- AlphaProteo generates novel proteins for biology and health researchdeepmind.google
- Reimagining Drug Discovery Process with AI - Isomorphic Labsisomorphiclabs.com
- Evo 2 Can Design Entire Genomesasimov.press
- How AI Revolutionized Protein Science, but Didn’t End It | Quanta Magazinequantamagazine.org
- One-shot design of functional protein binders with BindCraftnature.com
- Teaching generative models to hallucinateblog.escalante.bio
- Protein World Model | Biohubbiohub.ai
- Anthrogenanthrogen.com
- DISCO — Teaching AI to Invent Enzymes Nature Never Imagineddisco-design.github.io
- Miniaturizing and modifying natural proteins with Raygun | Naturenature.com
- Google DeepMind and Isomorphic Labs introduce AlphaFold 3 AI modelblog.google
- De novo design of protein structure and function with RFdiffusion | Naturenature.com